IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
17 hedge funds and large institutions have $293K invested in ImmunoCellular Therapeutics, Ltd. in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$28.4K | |
| 2 | -$23K | |
| 3 | -$10K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.29K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$5K |